Horst Rückoldt

Title: Horst Rückoldt: Innovator in Respiratory Treatment

Introduction

Horst Rückoldt is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of respiratory medicine through his innovative research and development. His work focuses on improving treatments for respiratory disorders, particularly in infants and adults.

Latest Patents

Rückoldt holds a patent for a groundbreaking pharmaceutical composition aimed at treating respiratory disorders. This patent, titled "Combination of C1-INH and lung surfactant for the treatment of respiratory disorders," specifically addresses infant respiratory distress syndrome and acute lung injury, including adult respiratory distress syndrome. The composition combines C1 esterase inhibitor (C1-INH) with lung surfactant, which includes a lung surfactant protein. This innovative approach has the potential to significantly enhance treatment outcomes for patients suffering from these serious conditions.

Career Highlights

Throughout his career, Rückoldt has been associated with Altana Pharma AG, a prominent pharmaceutical company known for its commitment to developing effective medical solutions. His work at Altana Pharma AG has allowed him to collaborate with leading experts in the field and contribute to advancements in respiratory therapies.

Collaborations

Rückoldt has worked alongside esteemed colleagues, including Dietrich Häfner and Paul-Georg Germann. These collaborations have fostered a productive environment for innovation and have led to the development of effective treatments for respiratory disorders.

Conclusion

Horst Rückoldt's contributions to respiratory medicine through his patent and work at Altana Pharma AG highlight his dedication to improving patient care. His innovative approach to treating respiratory disorders showcases the importance of research and collaboration in the medical field.